Philip J. Barter
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease(2005)3,485 cited
- → Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial(2005)3,260 cited
- → Effects of Torcetrapib in Patients at High Risk for Coronary Events(2007)3,113 cited
- → New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk(2010)2,224 cited
- → Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome(2012)2,011 cited
- → Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity(2020)1,795 cited